✦ LIBER ✦

Safety and Efficacy of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease: 2 Years of Treatment in Phase III Trials and an Extension Study

✍ Scribed by Ari Zimran; Madhulika Kabra; Pilar Giraldo; Marie-Françoise Ben Dridi; Deborah Elstein; Neerja Gupta; David Zahrieh; Eric Crombez; Hadhami Ben Turkia

Book ID: 116989671
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 50 KB
Volume: 105
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2011.11.187

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two-Year Efficacy And Safety Of Velagluc

Two-Year Efficacy And Safety Of Velaglucerase Alfa In Patients With Type 1 Gaucher Disease Switching From Imiglucerase: Phase III Trial HGT-GCB-039 And Extension

✍ Eric Crombez; Priya Kishnani; Hadhami Ben Turkia; Derlis Gonzalez; Ari Zimran; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Safety and efficacy of long-term velaglu

Safety and efficacy of long-term velaglucerase alfa therapy in treatment-naïve adults with type 1 Gaucher disease: results from Phase III trials

✍ Giraldo, Pilar; Zimran, Ari; Mehta, Atul; Hughes, Derralynn; Hangartner, Thomas 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 265 KB

49. Five-year safety and efficacy of vel

49. Five-year safety and efficacy of velaglucerase alfa in Gaucher disease type 1: Experience in clinic and home settings

✍ Deborah Elstein; Ari Zimran; Gabriel M. Cohn; Kiran Bhirangi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Safety and efficacy of long-term enzyme

Safety and efficacy of long-term enzyme replacement therapy with velaglucerase alfa in patients with type 1 Gaucher disease transitioned from imiglucerase

✍ Elstein, Deborah; Giraldo, Pilar; Mehta, Atul; Pastores, Gregory; Rhead, William 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 367 KB

A 7-year open-label study of clinical pa

A 7-year open-label study of clinical parameters and therapeutic goals in patients with type 1 Gaucher disease receiving treatment with velaglucerase alfa: Updating the long-term experience with velaglucerase alfa

✍ Elstein, Deborah; Cohn, Gabriel; Zahrieh, David; Crombez, Eric; Zimran, Ari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

An open-label long-term phase III extens

An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia

✍ Hiroyoshi Ohta,Hiroshi Oka,Chie Usui,Masayuki Ohkura… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 235 KB